• Latest Posts

Poxel granted orphan drug designation for kidney disease treatment

Poxel’s Diabetes Drug Wins Japan Nod, But Competition Remains Fierce

French First-in-Class Diabetes Drug Nails Phase III Trial

French Biotech Takes its Oral Diabetes Drug to Phase III

Healthcare-Biotech Partnership Pledges to Take its Type 2 Diabetes Treatment Worldwide


Poxel raises €26.5M to support Phase III trial in Diabetes

Poxel is Looking towards Japan’s Lucrative Diabetes Market

After its IPO, Poxel maintains its promise to develop a new Type 2 diabetes drug